Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes.
暂无分享,去创建一个
Lisa M Bodnar | Lynn T Singer | Barbara H Hanusa | B. Hanusa | D. Bogen | K. Wisner | E. Moses-Kolko | L. Bodnar | J. Perel | Eydie L Moses-Kolko | Katherine L Wisner | Dorothy K Y Sit | Debra L Bogen | Diane F Hunker | James M Perel | Sonya Jones-Ivy | L. Singer | Diane F. Hunker | D. Sit | S. Jones-Ivy
[1] Mark Walker,et al. Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. , 2006, American journal of obstetrics and gynecology.
[2] Olga V. Demler,et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). , 2003, JAMA.
[3] P. Hallberg,et al. Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn. , 2006, The New England journal of medicine.
[4] S. Hernández-Díaz,et al. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. , 2007, The New England journal of medicine.
[5] L. Altshuler,et al. Placental passage of antidepressant medications. , 2003, The American journal of psychiatry.
[6] Susan R. Johnson,et al. Assessing stressful life events associated with childbearing: The peripartum events scale , 1986 .
[7] G. Koren,et al. Neurodevelopment of children exposed in utero to antidepressant drugs , 1997, The New England journal of medicine.
[8] Assuring Healthy Outcomes,et al. Preterm Birth : Causes , Consequences , and Prevention , 2005 .
[9] M. Werler,et al. Predictive value of minor anomalies. I. Association with major malformations. , 1987, The Journal of pediatrics.
[10] U. Ekblad,et al. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. , 2003, Archives of general psychiatry.
[11] S. Rasmussen,et al. Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn. , 2006, The New England journal of medicine.
[12] P. Reebye,et al. Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications. , 2006, The American journal of psychiatry.
[13] R. Davis,et al. Outcomes of prenatal antidepressant exposure. , 2002, The American journal of psychiatry.
[14] B. Hanusa,et al. Postpartum Depression: A Randomized Trial of Sertraline Versus Nortriptyline , 2006, Journal of clinical psychopharmacology.
[15] L. Shulman. Increasing use of antidepressants in pregnancy , 2008 .
[16] F. A. Pedersen,et al. Minor physical anomalies and behavior in preschool children. , 1968, Child development.
[17] J. T. Cox,et al. Nutrition during pregnancy. , 2008, Obstetrics and gynecology clinics of North America.
[18] Jennita Reefhuis,et al. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. , 2007, The New England journal of medicine.
[19] D. Stoffer,et al. The effects of prenatal alcohol use on the growth of children at three years of age. , 1991, Alcoholism, clinical and experimental research.
[20] S. Thornton,et al. Preterm Birth: Causes, Consequences and Prevention , 2008 .
[21] J. Mintz,et al. Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. , 2007, The American journal of psychiatry.
[22] K. Jones,et al. Birth outcomes in pregnant women taking fluoxetine. , 1996, The New England journal of medicine.
[23] J. Hennen,et al. Birth outcomes following prenatal exposure to antidepressants. , 2007, The Journal of clinical psychiatry.
[24] K. Ormond,et al. PREGNANCY OUTCOME FOLLOWING MATERNAL USE OF THE NEW SELECTIVE SEROTONIN REUPTAKE INHIBITORS : A PROSPECTIVE CONTROLLED MULTICENTER STUDY , 1998 .
[25] B. Källén. Neonate characteristics after maternal use of antidepressants in late pregnancy. , 2004, Archives of pediatrics & adolescent medicine.
[26] Jan M Friedman,et al. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. , 2007, The New England journal of medicine.
[27] Andrew Bate,et al. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis , 2005, The Lancet.
[28] D. Stewart,et al. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. , 2002, The American journal of psychiatry.
[29] R. Post,et al. Graphic representation of the life course of illness in patients with affective disorder. , 1988, The American journal of psychiatry.
[30] R. Casper. Neonatal Signs After Late In Utero Exposure to Serotonin Reuptake Inhibitors: Literature Review and Implications for Clinical Applications , 2006 .
[31] R. Ehrenkranz. Neonatal Outcomes After Prenatal Exposure to Selective Serotonin Reuptake Inhibitor Antidepressants and Maternal Depression Using Population-Based Linked Health Data , 2007 .
[32] P. Neuvonen,et al. Risks Associated With Selective Serotonin Reuptake Inhibitors in Pregnancy , 2005, Obstetrics and gynecology.
[33] H. Hoyme,et al. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. , 2003, The Journal of pediatrics.
[34] L. Sirota,et al. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. , 2006, Archives of pediatrics & adolescent medicine.
[35] J. Ware,et al. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. , 1996, Medical care.
[36] S. Hernández-Díaz,et al. Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn , 2006, The New England journal of medicine.
[37] M. Reiff. Perinatal outcome following third trimester exposure to paroxetine. , 2003 .
[38] B. Källén,et al. Delivery outcome after the use of antidepressants in early pregnancy , 1999, European Journal of Clinical Pharmacology.
[39] M. Greene. Teratogenicity of SSRIs--serious concern or much ado about little? , 2007, The New England journal of medicine.